SEC Form 4 · accession 0001209191-18-051268
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela G Marrone
Officer — CEO · Director
Period of report
Sep 13, 2018
Accepted (ET)
Sep 17, 2018 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 13, 2018 | M | 47,794 | $1.19 | A | 843,103 | D | |
| Common StockF1 | Sep 13, 2018 | F | 34,987 | $2.02 | D | 808,116 | D | |
| Common Stock | holding | — | — | — | 53,134 | I | Jointly with Spouse | |
| Common StockF2 | holding | — | — | — | 6,442 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F3 | $1.19 | Sep 13, 2018 | M | 47,794 | D | — | Oct 22, 2018 | Common Stock | 47,794 | 0 | D |
Explanation of responses
- F1Represents (i) 28,217 shares withheld to cover the exercise price for the purchase of common stock, and (ii) 6,770 shares withheld to satisfy Company tax withholding obligations. The difference between the number of options exercised (47,794) and the number of shares withheld to pay exercise price and taxes (34,987) results in a net settlement of 12,807 shares.
- F2Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
- F3The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of November 1, 2008, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.